These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6385288)

  • 21. Responses to nifedipine by patients with Raynaud's disease and Raynaud's phenomenon secondary to another disease.
    Riccio A; Del Puente A; Farinaro C; Scarpa R; Oriente P; Rocco P; Gioia M
    Clin Ther; 1987; 9(2):232-7. PubMed ID: 3568066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nifedipine treatment of Raynaud's phenomenon in a paediatric age.
    Matucci Cerinic M; Falcini F; Bartolozzi G; Volpi M
    Int J Clin Pharmacol Res; 1985; 5(1):67-9. PubMed ID: 3997315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reserpine in Raynaud's phenomenon.
    Dimitriu CG; Florian G
    Lancet; 1970 Dec; 2(7684):1199. PubMed ID: 4098477
    [No Abstract]   [Full Text] [Related]  

  • 24. Controlled double-blind trial of dazoxiben and nifedipine in the treatment of Raynaud's phenomenon.
    Ettinger WH; Wise RA; Schaffhauser D; Wigley FM
    Am J Med; 1984 Sep; 77(3):451-6. PubMed ID: 6540986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized double blind cross-over trial of nifedipine in the treatment of primary Raynaud's phenomenon.
    Corbin DO; Wood DA; Macintyre CC; Housley E
    Eur Heart J; 1986 Feb; 7(2):165-70. PubMed ID: 3516704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlled trial of nifedipine in the treatment of Raynaud's phenomenon.
    Smith CD; McKendry RJ
    Lancet; 1982 Dec; 2(8311):1299-301. PubMed ID: 6128596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of nifedipine therapy on pulmonary Raynaud's in primary Sjögren's syndrome.
    Joseph BZ; Organek HW; Grant A; Axelrod DA
    Clin Exp Rheumatol; 1988; 6(4):409-10. PubMed ID: 3229032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intra-arterial reserpine for Raynaud's syndrome. Systemic reactions without therapeutic benefit.
    Surwit RS; Gilgor RS; Duvic M; Allen LM; Neal JA
    Arch Dermatol; 1983 Sep; 119(9):733-5. PubMed ID: 6614959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nifedipine treatment for Raynaud's phenomenon.
    Kahan A; Amor B; Menkes CJ
    Arthritis Rheum; 1984 Aug; 27(8):959-60. PubMed ID: 6466401
    [No Abstract]   [Full Text] [Related]  

  • 30. Griseofulvin in Raynaud's disease.
    Hasker WE
    Lancet; 1970 Nov; 2(7683):1136. PubMed ID: 4097937
    [No Abstract]   [Full Text] [Related]  

  • 31. Raynaud's phenomenon and nifedipine.
    Kraus A
    J Rheumatol; 1989 Jul; 16(7):1013. PubMed ID: 2597264
    [No Abstract]   [Full Text] [Related]  

  • 32. Suppression of Raynaud's phenomenon by methyldopa.
    Varadi DP; Lawrence AM
    Arch Intern Med; 1969 Jul; 124(1):13-8. PubMed ID: 5791479
    [No Abstract]   [Full Text] [Related]  

  • 33. [The effectiveness of alpha receptor blockage with phentolamine in Raynaud's syndrome].
    Brecht T; Hengstmann J; Wirtz J; Trübestein G
    Verh Dtsch Ges Inn Med; 1978; (84):1406-8. PubMed ID: 217191
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of Raynaud's phenomenon with calcium channel blockers.
    Smith CR; Rodeheffer RJ
    Am J Med; 1985 Feb; 78(2B):39-42. PubMed ID: 3976694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Raynaud's phenomenon: state of the art 1998.
    Ho M; Belch JJ
    Scand J Rheumatol; 1998; 27(5):319-22. PubMed ID: 9808392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of calcinosis circumscripta and Raynaud's phenomenon.
    Meyers D
    Med J Aust; 1976 Sep; 2(12):457. PubMed ID: 994932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nifedipine and Raynaud's phenomenon.
    Kahan A; Weber S; Amor B; Saporta L; Hodara M; Degeorges M
    Ann Intern Med; 1981 Apr; 94(4 pt 1):546. PubMed ID: 7212523
    [No Abstract]   [Full Text] [Related]  

  • 38. Nifedipine: two new uses.
    Conner CS
    Drug Intell Clin Pharm; 1983 Jun; 17(6):457-8. PubMed ID: 6861634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An experimentally controlled evaluation of the effect of inositol nicotinate upon the digital blood flow in patients with Raynaud's phenomenon.
    Holti G
    J Int Med Res; 1979; 7(6):473-83. PubMed ID: 391622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nifedipine and distal gangrene in Raynaud's phenomenon.
    Rivera Redondo J; Noguerado Asensio A; Alvaro-Gracia Alvaro JM; Laffón Roca A
    J Rheumatol; 1986 Apr; 13(2):464-5. PubMed ID: 3723511
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.